Source:http://linkedlifedata.com/resource/pubmed/id/17924995
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2008-1-10
|
pubmed:abstractText |
Capillary C4d deposition is a valuable marker of antibody-mediated rejection (AMR). In this analysis, flow cytometric detection of alloantibody-triggered C4d deposition to HLA antigen-coated microparticles ([C4d]FlowPRA) was evaluated for its value as a marker for C4d deposition in renal allografts. For comparative analysis, 105 first renal biopsies performed for graft dysfunction and an equal number of concurrent sera were subjected to immunohistochemistry and [C4d] plus standard [IgG]FlowPRA, respectively. C4d deposition/fixation was detected in 17 biopsies and, applying [C4d]FlowPRA HLA class I and II screening, also in a small number of corresponding sera (N = 20). IgG reactivity detected by standard [IgG]FlowPRA was more frequent (49% of sera). Comparing [C4d]FlowPRA screening with capillary C4d staining, we found a high level of specificity (0.92 [95% confidence interval: 0.86-0.98]), which far exceeded that calculated for [IgG]FlowPRA (0.60 [0.50-0.70]). [IgG]FlowPRA screening, however, turned out to be superior in terms of sensitivity (0.94 [0.83-1.05] vs. 0.76 [0.56-0.97] calculated for C4d-fixing panel reactivity). Remarkably, posttransplant single antigen testing for identification of complement-fixing donor-specific alloreactivities failed to improve the predictive value of FlowPRA-based serology. In conclusion, our results suggest that detection of complement-fixing HLA panel reactivity could provide a specific tool for monitoring of C4d-positive AMR.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Complement C4b,
http://linkedlifedata.com/resource/pubmed/chemical/HLA Antigens,
http://linkedlifedata.com/resource/pubmed/chemical/Isoantibodies,
http://linkedlifedata.com/resource/pubmed/chemical/Peptide Fragments,
http://linkedlifedata.com/resource/pubmed/chemical/complement C4d
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1600-6143
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
8
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
41-9
|
pubmed:meshHeading |
pubmed-meshheading:17924995-Adult,
pubmed-meshheading:17924995-Capillaries,
pubmed-meshheading:17924995-Complement C4b,
pubmed-meshheading:17924995-Complement Fixation Tests,
pubmed-meshheading:17924995-Female,
pubmed-meshheading:17924995-HLA Antigens,
pubmed-meshheading:17924995-Humans,
pubmed-meshheading:17924995-Isoantibodies,
pubmed-meshheading:17924995-Kidney,
pubmed-meshheading:17924995-Kidney Transplantation,
pubmed-meshheading:17924995-Male,
pubmed-meshheading:17924995-Middle Aged,
pubmed-meshheading:17924995-Peptide Fragments,
pubmed-meshheading:17924995-Transplantation, Homologous
|
pubmed:year |
2008
|
pubmed:articleTitle |
In vitro detection of C4d-fixing HLA alloantibodies: associations with capillary C4d deposition in kidney allografts.
|
pubmed:affiliation |
Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|